鶹ýɫƬ

Journal News

How chronic pain shows up in urine

Researchers distinguish urinary pelvic pain from healthy controls — and from other chronic pain diseases
Renae   Crossing
May 10, 2022

Chronic pain diseases are underresearched — particularly for women, particularly with pelvic pain. . For people with urinary chronic pelvic pain syndrome, or UCPPS, the need to urinate is particularly frequent or urgent, or pelvic pain is prominent, or both. It’s often simply a diagnosis of exclusion, and there is a lack of effective treatments.

Urine sample

Using , researchers have been able to distinguish UCPPS from other chronic pain diseases, including myalgic encephalomyelitis/chronic fatigue syndrome, or ME/CFS, as well as fibromyalgia and irritable bowel syndrome.

According to in the journal 鶹ýɫƬ & Cellular Proteomics, lurking in urine all along were pronounced differences in the proteins related to chronic pain for different sexes — and leads for diagnosis and treatment.

We often think of pain in terms of blunt force, but the workings of chronic pain are more like pulling thousands of tiny strings in the theater of a cell. To develop new treatments and diagnostics, we need to know which proteins are pulling strings or playing other parts.

Finding those proteins is the most powerful aspect of this study, according to first author John Froehlich, professor of surgery at Harvard Medical School. He said his team is “measuring the real things that carry out functions,” along with the upstream bosses of those things.

Why not a blood test? Urine is close to the pelvis and can be more sensitive than blood (or not as good at homeostasis). Also, patients are happy: one less jab for a blood draw.

In a , the scientists received 244 urine samples from the masses, (that is, for the technique called mass spectrometry), blasted them to smithereens — smithereens ordered by mass and charge, for identification — and loaded the data onto the Proteome Discoverer version 2.2.

What did they find?

The levels of .

There were parts of the scaffolds in between cells, and proteins involved in inflammation. The researchers found proteins known for increasing bleeding (previously implicated in UCPPS), for reducing the migration of immune cells, and for the development of epithelial tissue — the lining around blood vessels and organs or their cavities. They also found proteins that work in the postal service of cells, the Golgi.

But what if these protein patterns were due to chronic pain generally, not uniquely UCPPS?

The scientists ran comparisons with people with other chronic pain diseases, and uniquely in UCPPS. Next, the team wants to conduct a larger study to see if these unconventional fingerprints correlate with disease or duration.

Froehlich said he would be “tickled” if other researchers mined the to help people with chronic pain diseases. The growing global burden of ME/CFS includes an .

Froehlich calls corresponding author a “powerhouse” behind this research.

He also credits his mother. After completing a Ph.D. on (“My mom was a midwife”), Froehlich pivoted to a fluid with its own sort of richness. He simply changed streams.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Renae   Crossing

Renae Crossing is a writer and former teacher. She holds a first-class master’s degree in life science from the Hong Kong University of Science and Technology and a first-class master’s in teaching from the University of Melbourne.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Profile

Understanding the lipid link to gene expression in the nucleus

Aug. 11, 2025

Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Journal News

Receptor antagonist reduces age-related bone loss in mice

Aug. 6, 2025

Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Journal News

Engineered fusion protein targets kiwifruit pathogen

Aug. 6, 2025

Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.